Analysis of NLRP3 in the Development of Allergic Airway Disease in Mice
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The contribution of NLRP3, a member of the nucleotide-binding domain leucine-rich repeat–containing (NLR) family, to the development of allergic airway disease is currently controversial. In this study, we used multiple allergic asthma models to examine the physiologic role of NLRP3. We found no significant differences in airway eosinophilia, histopathologic condition, mucus production, and airway hyperresponsiveness between wild-type and Nlrp3−/− mice in either acute (alum-dependent) or chronic (alum-independent) OVA models. In addition to the OVA model, we did not detect a role for NLRP3 in the development of allergic airway disease induced by either acute or chronic house dust mite Ag exposure. Although we did not observe significant phenotypic differences in any of the models tested, we did note a significant reduction of IL-13 and IL-33 in Nlrp3−/− mice compared with wild-type controls in the chronic OVA model without added alum. In all of the allergic airway disease models, the NLRP3 inflammasome-associated cytokines IL-1β and IL-18 in the lung were below the level of detection. In sum, this report surveyed four different allergic asthma models and found a modest and selected role for NLRP3 in the alum-free OVA model. However, this difference did not greatly alter the clinical outcome of the disease. This finding suggests that the role of NLRP3 in allergic asthma must be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542 · cited 7×
“Nlrp3, Pycard, and Casp-1 mice were found to have significantly attenuated airway inflammation, Ig Ab production, and cytokine release in response to OVA (2, 9).”
BackgroundMethodInfluentialSutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J., Coyle, A. J., Galán, J. E., Askenase, P. W., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.004 · Cited by 980 · cited 1×
“This study used Nlrp3 mice that have been previously described (17).”
MethodDunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Cited by
Kim, H. Y., Lee, H. J., Chang, Y.-J., Pichavant, M., Shore, S. A., Fitzgerald, K. A., Iwakura, Y., Israel, E., Bolger, K., Faul, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3423 · Cited by 635
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
Bruchard, M., Rebé, C., Derangère, V., Togbé, D., Ryffel, B., Boidot, R., Humblin, E., Hamman, A., Chalmin, F., Berger, H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3202 · Cited by 395
de Zoete, M. R., Palm, N. W., Zhu, S., & Flavell, R. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016287 · Cited by 379
Allergens and the airway epithelium response: Gateway to allergic sensitization
Lambrecht, B. N., & Hammad, H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.036 · Cited by 328
Intestinal antimicrobial peptides during homeostasis, infection, and disease
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00310 · Cited by 252
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
“To better characterize these observations, we used a semiquantitative scoring system, previously proven to be effective in evaluating goblet cell hyperplasia and mucus production in the lungs, to quantify mucus production in the colon (37, 38).”
MethodSelf-citationSpacova, I., Van Beeck, W., Seys, S., Devos, F., Vanoirbeek, J., Vanderleyden, J., Ceuppens, J., Petrova, M., & Lebeer, S. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1766345 · Cited by 87
“For example, while the exact role of IL-1β in the development of allergic asthma is unclear, it might contribute to airway inflammation by exacerbating the innate immune response.(32) IL-1β was previously shown to induce AHR through direct alteration of mitogen-activated protein kinase (MAPK) pathways in airway cells.”
BackgroundLi, R., Wang, J., Li, R., Zhu, F., Xu, W., Zha, G., He, G., Cao, H., Wang, Y., & Yang, J. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.002 · Cited by 68
The role of NLRP3 inflammasome in type 2 inflammation related diseases
Xu, S., Wang, D., Tan, L., & Lu, J. (2024) · Autoimmunity · doi:10.1080/08916934.2024.2310269 · Cited by 43
Metadata
- Authors
- Allen, I. C., Jania, C. M., Wilson, J. E., Tekeppe, E. M., Hua, X., Brickey, W. J., Kwan, M., Koller, B. H., Tilley, S. L., & Ting, J. P.-Y.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03
- Volume
- 188
- Issue
- 6
- Pages
- 2884-2893
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2115702526
- Cited by
- 96
- References
- 3
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.